Literature DB >> 16703581

Plasma concentrations of soluble CTLA-4, CD28, CD80 and CD86 costimulatory molecules reflect disease severity of acute asthma in children.

W K Ip1, C K Wong, T F Leung, C W K Lam.   

Abstract

Recent studies have demonstrated an elevation of plasma soluble costimulatory molecules B7.1 (CD80) and B7.2 (CD86), and their T lymphocyte counter receptors cytotoxic T lymphocyte associated antigen-4 (CTLA-4) and CD28 in asthmatic patients. We hypothesized that these costimulatory molecules may reflect the severity of asthma and investigated the longitudinal changes of these soluble costimulatory molecules, and their clinical significance in children with an asthmatic exacerbation. Sixteen children hospitalized for asthmatic exacerbation were recruited and treated with systemic corticosteroid (CS) for 5 days. Plasma total Immunoglobulin E (IgE) and eosinophil cationic protein (ECP) concentrations were measured by microparticle immunoassay and fluorescence enzyme immunoassay, respectively. Soluble CTLA-4 (sCTLA-4), sCD28, sCD80, and sCD86 concentrations in plasma were measured by enzyme-linked immunosorbent assay, and their relationships with asthma severity, total IgE, ECP concentrations, and blood eosinophil count were analyzed. Plasma sCTLA-4, sCD28, sCD80, and sCD86 concentrations in patients were highest during the acute attack. They decreased significantly with a parallel increase of peak expiratory flow rate (PEFR) after CS treatment (all P < 0.05). Plasma sCTLA-4, sCD28, and sCD86 concentrations of patients at recruitment were inversely correlated with PEFR, whereas plasma sCD28 and sCD86 concentrations correlated positively with eosinophil count and plasma ECP concentration (all P < 0.05). Although there was no such correlation with IgE concentration, sCD28 was correlated very significantly with eosinophil count (r = 0.83, P < 0.0001). In conclusion, plasma sCTLA-4, sCD28, sCD86, and sCD80 concentrations may reflect the severity of acute asthma and more studies on larger cohorts are needed to assess whether these markers are useful for assessing asthmatic exacerbation in children.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16703581     DOI: 10.1002/ppul.20432

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  7 in total

1.  Aberrant expression of costimulatory molecules in splenocytes of the mevalonate kinase-deficient mouse model of human hyper-IgD syndrome (HIDS).

Authors:  Elizabeth J Hager; Jon D Piganelli; Hubert M Tse; K Michael Gibson
Journal:  J Inherit Metab Dis       Date:  2011-05-24       Impact factor: 4.982

2.  Soluble TIM3 and Its Ligands Galectin-9 and CEACAM1 Are in Disequilibrium During Alcohol-Related Liver Disease and Promote Impairment of Anti-bacterial Immunity.

Authors:  Antonio Riva; Elena Palma; Dhruti Devshi; Douglas Corrigall; Huyen Adams; Nigel Heaton; Krishna Menon; Melissa Preziosi; Ane Zamalloa; Rosa Miquel; Jennifer M Ryan; Gavin Wright; Sarah Fairclough; Alexander Evans; Debbie Shawcross; Robert Schierwagen; Sabine Klein; Frank E Uschner; Michael Praktiknjo; Krum Katzarov; Tanya Hadzhiolova; Slava Pavlova; Marieta Simonova; Jonel Trebicka; Roger Williams; Shilpa Chokshi
Journal:  Front Physiol       Date:  2021-03-10       Impact factor: 4.566

Review 3.  Soluble immune checkpoints in cancer: production, function and biological significance.

Authors:  Daqian Gu; Xiang Ao; Yu Yang; Zhuo Chen; Xiang Xu
Journal:  J Immunother Cancer       Date:  2018-11-27       Impact factor: 13.751

4.  A functional CD86 polymorphism associated with asthma and related allergic disorders.

Authors:  Thomas Juhl Corydon; Annette Haagerup; Thomas Gryesten Jensen; Helle Glud Binderup; Mikkel Steen Petersen; Keld Kaltoft; Jørgen Vestbo; Torben Arvid Kruse; Anders Dupont Børglum
Journal:  J Med Genet       Date:  2007-05-18       Impact factor: 6.318

5.  Effects of different up-dosing regimens for hymenoptera venom immunotherapy on serum CTLA-4 and IL-10.

Authors:  Anna Maria Riccio; Daniele Saverino; Giampaola Pesce; Anthi Rogkakou; Maurizio Severino; Patrizia Bonadonna; Erminia Ridolo; Marina Mauro; Giorgio Walter Canonica; Marcello Bagnasco; Giovanni Passalacqua
Journal:  PLoS One       Date:  2012-06-19       Impact factor: 3.240

6.  Performance of Eosinophil Cationic Protein as a Biomarker in Asthmatic Children.

Authors:  Sheel N Shah; Jocelyn R Grunwell; Ahmad F Mohammad; Susan T Stephenson; Gerald B Lee; Brian P Vickery; Anne M Fitzpatrick
Journal:  J Allergy Clin Immunol Pract       Date:  2021-03-27

7.  Cytotoxic T-lymphocyte associated antigen 4 polymorphisms and asthma risk: a meta-analysis.

Authors:  Wei Nie; Jiquan Chen; Qingyu Xiu
Journal:  PLoS One       Date:  2012-07-26       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.